Oncologists, immunologists, and related scientists from around the world review the field in 14 studies ranging from basic science on how to identity peptides, through what would be good target epitopes and delivery methods, to clinical trials in a variety of different cancers. The topics include mutant oncogenes and tumor suppressor gene products and fusion proteins created by chromosomal translocations as targets for cancer vaccines, the critical dependence of the peptide delivery method on the efficacy of epitope-focused immunotherapy, prostate cancer, cervical cancer, melanoma, and renal cell carcinoma. The text is also available on the Web. Annotation c. Book News, Inc., Portland, OR (booknews.com)
